Skip to content

5 mg Rosuvastatin will be orally administered once daily for two years. Target LDL-C levels are 80 mg/dL for primary prevention, and 70 mg/dL for secondary prevention. If these levels are not achieve

2 trials

Sponsors

Japan Atherosclerosis Regressive Treatment Study Group

Conditions

Hypercholesterolemia